Drug
Lixivaptan
Lixivaptan: highest development phase Phase 3, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| lixivaptan NCT00660959 | Phase 3 | Hyponatremia With Normal Extracellular Fluid Volume |
Latest
No recent events.
Follow Lixivaptan on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.